36th Annual JPM Healthcare Conference

gtmrick
December 25, 2017
Uncategorized

In 2018 Vasomune Therapeutics will be at the 36TH ANNUAL JPM HEALTHCARE CONFERENCE, San Francisco, California

About

Vasomune Therapeutics is a private biotechnology company developing the next generation of medications to harness the body’s ability to defend against illness by modifying cellular response to disease.

Close Menu

You Might Also Like

A New Flu Drug Works Astoundingly Well—By Not Targeting the Flu at All

The COVID-19 Coronavirus Leads to Acute Respiratory Distress Syndrome (ARDS)

Preventing the flu: Researchers looking for a new approach

About

Vasomune Therapeutics 2020 © All Rights Reserved.